Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study
- Author(s)
- Herling, M; Dearden, C; Zaja, F; El-Sharkawi, D; Ding, W; Bellido, M; Khot, A; Tick, L; Jacobsen, E; Eyre, TA; Roos-Weil, D; Kadia, T; Lucchini, E; Pflug, N; Davids, MS; Pena, G; Mukherjee, N; Badawi, M; Vizkelety, T; Staber, PB;
- Details
- Publication Year 2024-02-27,Volume 8,Issue #4,Page 842-845
- Journal Title
- Blood Advances
- Publication Type
- Research article
- Publisher
- American Society of Hematology
- Keywords
- Humans; *Leukemia, Prolymphocytic, T-Cell; Adenine/*analogs & derivatives; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use; *Piperidines; *Sulfonamides
- Department(s)
- Clinical Haematology
- Publisher's Version
- https://doi.org/10.1182/bloodadvances.2023012248
- Open Access at Publisher's Site
https://doi.org/10.1182/bloodadvances.2023012248- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-03-12 06:47:04
Last Modified: 2024-03-12 06:47:25